NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Mass Layoffs Hit Ariad Employees After Takeda's $5.2 Billion Buyout Deal March 29, 2017 5 Biotechs Awaiting FDA Decisions in January 2018 December 27, 2017 Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress August 30, 2017
Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress August 30, 2017
